06.08.26 -- New Insights Into ADC Analytical Strategies And Payload Innovation

Antibody-drug conjugates (ADCs) combine targeted antibody delivery with highly potent cytotoxic payloads, offering new options for difficult-to-treat cancers. But their complexity demands robust, phase-appropriate analytical strategies. Learn how comprehensive analytical approaches help ensure consistency, safety, and efficacy while accelerating development from discovery through commercialization.

The complex structure of ADCs creates unique manufacturing and analytical challenges, especially when validating cleaning processes and controlling residual payload contamination. Discover how highly sensitive detection methods and scalable bioconjugation platforms support safer manufacturing, improved quality control, and more efficient production.

Explore two novel ADC payloads engineered to support safer, more effective cancer therapeutics. Designed for streamlined evaluation and rapid integration into development programs, these next-generation payloads can help accelerate ADC discovery while delivering strong efficacy and safety performance.